NICHOL MELCHER: Open Payments
NPI 1487373551 · HAMBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,438 in 228 payments from 20 companies in 2025. Trend: 2023 $3,221 · 2024 $3,301 · 2025 $5,438
Food & beverage: $4,388Travel & lodging: $1,050
| Company | Payments | Amount |
|---|---|---|
| Neuronetics, Inc. | 3 | $1,174 |
| ABBVIE INC. | 57 | $1,162 |
| Otsuka America Pharmaceutical, Inc. | 33 | $652 |
| Neurocrine BioSciences, Inc. | 17 | $384 |
| Teva Pharmaceuticals USA, Inc. | 22 | $315 |
| Janssen Pharmaceuticals, Inc | 10 | $299 |
| Lundbeck LLC | 21 | $272 |
| Alkermes, Inc. | 7 | $186 |
| Axsome Therapeutics, Inc. | 14 | $182 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $144 |
Products named: NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, REXULTI, INGREZZA, SPRAVATO, ARISTADA, Auvelity, AUSTEDO XR.
Industry payments across NY — which companies pay providers there.
